AB0368 the Occurrence of Antibodies Depending on the Duration of Rheumatoid Arthritis

doi 10.1136/annrheumdis-2018-eular.6907
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Lethality of Patients With Rheumatoid Arthritis Depending on Adalimumab Administration: Imitation Modeling

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2009English

Thyroid Hormone Antibodies in Rheumatoid Arthritis

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
2009English

Emerging Therapies in Rheumatoid Arthritis: Focus on Monoclonal Antibodies

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Developing the Next Generation of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis

British Journal of Pharmacology
Pharmacology
2011English

The Importance of Antibodies and Other Molecules as Biomarkers in Rheumatoid Arthritis

Acta Scientific Medical Sciences
2019English

The Association of Anti-CCP Antibodies With Disease Activity in Rheumatoid Arthritis

Rheumatology International
RheumatologyAllergyImmunology
2008English

Pms34 - The Impact of Disease Duration and Disease Activity on the Cost of Rheumatoid Arthritis in Spain: Results From Burden of Rheumatoid Arthritis Across Europe a Socioeconomic Survey (Brass)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Influence of Cholinergic System on Rheumatoid Arthritis

Open Access Journal of Pharmaceutical Research
2019English

The Treatment of Rheumatoid Arthritis.

JAMA - Journal of the American Medical Association
Medicine
1929English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy